Tanuja Koppal, PhD
Editor in Chief

Although we continually evaluate and evolve our editorial coverage to stay in tune with the informational needs of our readers, the New Year is always a time for new beginnings. As people take time to reflect on the past year and think about what they are doing and how they can do it better, we at Drug Discovery & Development are doing the same. While our readers struggle to keep up with the latest techniques and trends in drug discovery technologies, our challenge lies in getting them the best information in the most effective manner.

It is often hard to disseminate breaking news via the monthly publication. Hence, in 2005 we will be fully exploiting our Internet capabilities to reach you faster. We will continue to have daily updated online news on our Web site. Along with our bimonthly newsletter, that includes a selection of important news and articles, we also will be launching a series of targeted newsletters to keep our readers informed of the latest developments in various disciplines. The first one, "Chemistry Updates," featuring news and articles on medicinal and process chemistry, will be launched early next year.

We will continue to bring you live, informative video broadcasts on specialized topics, with the support of our sponsors. The Webcasts that we broadcast this year on Early ADME Screening and Advances in Cellular Imaging were extremely successful with more than 500 registrants for each event. On February 15, 2005, we will launch our first online conference, BioDiscovery Expo. The two-day event includes three parallel tracks on RNAi, Biomarkers, and Expression Profiling and features presentations by prominent scientists from industry and academia. Details of the event, registration, and information on how to submit papers/posters are available on the event Web site

Traditionally DD&D has focused more on discovery and early development aspects of the drug pipeline. However, as the lines between drug discovery and drug development grow blurry and as integration and data sharing increases between discovery and the clinic, we find our editorial coverage reflecting that trend. In 2005, we will routinely feature articles on topics such as bioprocessing, scale-up, methods development, compliance, formulations, and drug delivery. We will also have articles on the clinical side that talk about biomarkers, clinical data management, and clinical outsourcing.

If you would like to contribute to the magazine, please don't hestitate to contact any of our editors. From a one-page opinion piece titled "Industry Insider" to full-length articles in the form of Research or Technology Reviews, there are many ways in which you can communicate with your peers. Also, check out our Web site for the latest editorial offerings, the 2005 editorial calendar, article submission guidelines, and editorial contacts. Thank you all for your continued feedback and support.